Dr. Dawud Lankford

Dr. Dawud Lankford
Dr Lankford is an Oakland and Walnut Creek based urologist, specializing in urologic oncology and penile aesthetics. He grew up in the Bay Area and attended the University of California, Berkeley, majoring in molecular and cellular biology. He earned his medical degree at Meharry Medical College in Nashville, TN with a dual Master’s Degree in public health from the University of California, Berkeley. His Master’s thesis was an investigational study that assessed the factors contributing to patient satisfaction and surgical outcome measures using standardized surveys. He completed his residency in Urology at New York Medical College in Valhalla, NY which included a core rotation at Memorial Sloan Kettering Cancer Center. He completed a clinical research fellowship in urologic oncology at the National Cancer Institute in Bethesda, MD contributing to breakthrough research in genitourinary cancer treatments. Lastly, he completed an endourology and robotics fellowship at New York Medical College in Valhalla, NY, where he was trained in all forms of minimally invasive surgical techniques for the treatment of urologic oncology. Dr. Lankford has a special interest in optimizing men’s health with a holistic view on health and wellness, patient satisfaction, exercise, and lifestyle changes which may influence positive outcomes after surgical procedures. He has a practice focus on penile prosthetics after therapies for prostate cancer.
Medical School:

Meharry Medical College


New York Medical College, Urology


New York Medical College, Endourology

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only